Concepedia

Leonardo Gomes da Fonseca

LG

Statistics

Publications

24

Citations

759

H-Index

17

Active since

2014

Affiliations

Instituto do Câncer do Estado de São Paulo(Current)

Universidade de São Paulo

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

Universitat de Barcelona

Leonardo Gomes da Fonseca is an author at Instituto do Câncer do Estado de São Paulo specializing in medicine, oncology, and hepatology.

ORCID

Top concepts

Publications per year

2014–2025

24

Publications

24

Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial

Thomas Yau, Peter R. Galle, Thomas Decaens et al. · The Lancet · 2025 · 144 citations · Full text

Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study

Manuel de la Torre‐Aláez, Ana Matilla, Marı́a Varela et al. · Journal for ImmunoTherapy of Cancer · 2022 · 69 citations · Full text

Assessing the impact of COVID-19 on liver cancer management (CERO-19)

Sergio Muñoz, Víctor Sapena, Alejandro Forner et al. · JHEP Reports · 2021 · 60 citations · Full text

Malignancy-Related Hypercalcemia in Advanced Solid Tumors: Survival Outcomes

Ricardo Emanuel de Oliveira Ramos, Milena Perez Mak, Michel Alves et al. · Journal of Global Oncology · 2017 · 48 citations · Full text

Pre-treatment neutrophil-to-lymphocyte ratio affects survival in patients with advanced hepatocellular carcinoma treated with sorafenib

Leonardo Gomes da Fonseca, Romualdo Barroso‐Sousa, Afonso da Silva Alves Bento et al. · Medical Oncology · 2014 · 45 citations

, , +8

1–5 of 24